go back

Rhode Island rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Low / Median / High Price
$1,811,280.00 / $1,811,280.00 / $1,811,280.00
Aetna
Facility/Professional
Professional
Modifier
Low / Median / High Price
$557,317.93 / $557,317.93 / $579,610.65
BCBS
Facility/Professional
Facility
Modifier
Low / Median / High Price
$538,878.68 / $541,260.44 / $571,897.82
BCBS
Facility/Professional
Professional
Modifier
Low / Median / High Price
$557,317.93 / $557,317.93 / $557,317.93